Quarterly Results

202605 Results Summary

Revenue

The revenue stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Operating Profit

Operating Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

PBDT

PBDT stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Profit Before Tax

Profit Before Tax stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Net Profit

Net Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This represents a per cent year-on-year *(YoY) decline for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Company News

More

Earnings

CategoryQ4 FY25-26Q4 FY24-25Change %FY25-26FY24-25Change %
Total Revenue7,546.408,528.40-11.5133,700.2032,643.903.24
Expenses6,906.406,453.707.0127,246.7024,096.8013.07
Other Income480.00527.60-9.021,371.801,119.0022.59
Operating Profit640.002,074.70-69.157,825.309,666.10-19.04
Depreciation557.10454.7022.522,058.801,703.7020.84
Interest105.7065.6061.13373.80282.9032.13
Profit Before Tax199.702,005.20-90.045,392.707,679.50-29.78
Tax-21.60418.50-105.161,394.502,258.10-38.24
Net Profit221.301,586.70-86.054,157.605,725.20-27.38
CategoryQ4 FY25-26Q3 FY25-26Change %
Total Revenue7,546.408,753.40-13.79
Expenses6,906.406,838.900.99
Other Income480.00271.1077.06
Operating Profit640.001,914.50-66.57
Depreciation557.10521.006.93
Interest105.7094.4011.97
Profit Before Tax199.701,543.20-87.06
Tax-21.60353.60-106.11
Net Profit221.301,189.60-81.40

Research Reports

ActionTarget Price (₹)BrokerDateReports
Data Not Found

Financial Reports

Data not available.

Stock Prices Compare with Peers

Company1 Day1 Week1 Month3 Months6 Month1 Year
Data Not Found

Corporate Information

Company News

Nifty Healthcare below 100-WMA, down 8% from its peak; what charts say?

Amol Athawale of Kotak Securities believes that the short-term outlook for Nifty Healthcare remains uncertain and sentiment may turn negative in case the index falls below 13,500 levels.

Updated On: 06 Apr 2026 | 11:19 AM IST

Axis Bank, Voda Idea: 28 Nifty 500 stocks reclaim 200-DMA today; full list

Among others Dr. Reddy's, Apollo Hospitals, M&M Finance, Muthoot Finance, Tata Power, Balrampur Chini and Sammaan Capital soared up to 20% from recent lows to cross the long-term average, shows data.

Updated On: 25 Mar 2026 | 11:55 AM IST

10 pharma firms launch semaglutide in India; Nomura sees ₹12k-cr mkt

Companies including Dr. Reddy's Laboratories, Sun Pharma, Zydus Lifesciences, Natco Pharma, Alkem Laboratories, and Torrent Pharmaceuticals have developed their own formulations

Updated On: 23 Mar 2026 | 9:58 AM IST

Analyst suggests Nifty strategy; bets on Oil India, Dr Reddy's Labs

Ajit Mishra of Religare Broking recommends Nifty strategy and two stocks to buy; check details here

Updated On: 12 Mar 2026 | 6:30 AM IST

Nifty Pharma index hits 52-week high; Ipca, Aurobindo rally up to 4%

In the past one month, the Nifty Pharma index has rallied 4.5 per cent, as against 7.8 per cent decline in the benchmark Nifty 50.

Updated On: 11 Mar 2026 | 3:02 PM IST

Stocks to Watch today: UltraTech Cement, Dr Reddy's Labs, Tata Power, GNFC

Stocks to Watch today, March 9, 2026: HDFC Life Insurance, Tata Power, GNFC, Avenue Supermarts, and Meesho are among the top stocks to remain in focus today

Updated On: 09 Mar 2026 | 7:03 AM IST

Stocks to Watch: OMCs, Garden Reach, Petronet LNG, JK Tyre, DCX Systems

Stocks to Watch today: OMCs, Garden Reach, Petronet LNG, SAMHI Hotels, DCX Systems, JK Tyre and Dr Reddy's are among the stocks to watch today, March 06, 2026

Updated On: 06 Mar 2026 | 7:49 AM IST

Breakout stocks: BEL, Dr Reddy's, Triveni can gain up to 12%, says chartist

Bullish signs on charts: Hitesh Tailor of Choice Broking explains that BEL has witnessed a decisive symmetrical triangle breakout, while Dr Reddy's and Triveni Engineering saw 'Golden Crossovers'.

Updated On: 27 Feb 2026 | 11:13 AM IST

Nifty Pharma index soars 7% thus far in February; nears 52-week high

Thus far in the month of February 2026, Laurus Labs surged 13%, while Sun Pharmaceutical Industries and Torrent Pharmaceuticals soared 11% each.

Updated On: 26 Feb 2026 | 3:01 PM IST

Dr Reddy's likely to launch generic semaglutide Obeda in India in March

Hyderabad-based Dr Reddy's has applied to trademark the Obeda brand and logo, a government filing showed

Updated On: 25 Feb 2026 | 3:16 PM IST
More